Heart failure (HF) is the most common hospital discharge diagnosis among the elderly. It accounts for nearly 1.4 million hospitalizations and $21 billion in spending per year in the United States. Readmission rates remain high with estimates ranging from 15-day readmission rates of 13%, 30-day readmission rates of 25%, to 6-month readmission rates of 50%. The Center for Medicare and Medicaid Services (CMS) has started penalizing hospitals with higher than expected readmission rates. Objective: To identify factors associated with increased 30-day readmission among heart failure patients in an inner-city community-based teaching hospital. Methods: A retrospective cohort study of patients with principal discharge diagnosis of acute Heart Failure between 2008 and 2010. Demographic, clinical characteristics, length of stay, discharge medications, disposition and all-cause 30-day readmission were abstracted from the hospital's administrative database and analyzed. Results: Almost 8 out of 10 patients were 65 years or older (mean age 75.4 ± 14.3) and 51% were female. The in-hospital mortality rate was 2.7% (95% confidence interval [CI], 1.6% -4.3%) with a median length of stay of 5.0 days (Interquartile range of 3 -7) . The all-cause 30-day readmission rate was 17.7% (95% CI 14.9% -20.8%). By univariate analysis, readmissions were predicted by black race, prior history of HF, length of stay of more than 7 days and discharge to extended care facility (ECF). By logistic regression analysis, black race (OR 2.4, 95% CI 1.4 -3.8), prior history of HF (OR 1.7, 95% CI 1.5 -2.6) and discharge to an ECF (OR 2.4, 95% CI 1.5 -3.7) were the independent predictors of 30-day readmission. HF accounted for 43.7% of the readmissions. Conclusion: Prior diagnosis of HF, black race, and discharge to an ECF were independent predictors of 30-day readmission in this cohort, and over half of the readmissions were for reasons other than HF.
Introduction
The most common cause of both hospitalizations and readmissions in the medicare program is heart failure (HF) leading to nearly 1.4 million hospitalizations in 2007 alone [1] [2] . More than $39 billion was spent on the care of patients with heart failure in 2010 in the United States with about $21 billion spent on hospitalization [3] .
Readmission rates after initial hospitalization for HF remain high. Patients experience an estimated 15-day readmission rate of 13%, a 30-day readmission rate of 25%, and 6-month readmission rates of 50% [4] [5] . These readmissions have been estimated to cost the American public >$15 billion per year [6] . Nearly 90% of the readmissions including those of HF are potentially preventable [1] [6] .
Reducing readmissions has become a policy focus because it represents an opportunity to simultaneously improve quality and reduce costs. The National Quality Forum has endorsed hospital risk-standardized readmission rates (RSRRs) as performance measures, and the Centers for Medicare & Medicaid Services publicly report these rates. The Patient Protection Affordable Care Act of 2010 has created new incentives to reduce readmissions using the publicly reported measures. From fiscal year 2013, the Centers for Medicare have started penalizing hospitals with higher than average HF readmissions rates. Hospitals with high readmission rates can lose up to 3% of their medicare reimbursement by 2015 [7] .
Identification of high-risk patients prone to frequent readmissions is imperative to help clinicians focus their most resource-intensive disease management efforts on these patients. In addition, a better understanding of the major correlates of readmission could contribute to the development of more effective interventions. A number of predictors for HF have been identified, and research groups have proposed statistical models and risk scores to increase accuracy and precision to determine patient readmission risk after hospital discharge for HF [8] - [15] . Given the heterogeneous nature of the HF population, a "one-size fits-all" approach to risk stratification is not appropriate. Re-admission risks vary across population groups. This retrospective cohort study examines the predictors of heart failure readmission in an inner city hospital.
Method
This was a retrospective cohort study conducted in a 425-bed, inner-city, community-based, teaching hospital in the New England region of the United States. The catchment area of the hospital includes a large inner-city population with associated more affluent suburbs. The Institutional Review board (IRB) approved the study and waived requirement of informed consent from individual patients. All patients with a primary discharge diagnosis of heart failure between January 1, 2008 through December 31, 2010 were eligible for inclusion. Data were extracted from the administrative electronic database of the hospital using a uniform data abstract sheet. Abstracted records included demographic information (age, gender, race, ethnicity), payer status, admission and discharge diagnoses, co-morbid conditions, medications, major echocardiographic findings, length of stay, inhospital mortality and discharge disposition.
Data Analysis
For purposes of the study, subjects were categorized on the basis of race and ethnicity into White non-Hispanics (WHITES), Black non-Hispanics (Blacks), Hispanics, and all others. Patients' payer status was categorized as Medicare, Medicaid (including city welfare), Commercial Insurance, and self-Pay. Discharge disposition was classified as Home (with or without services), or Extended Care facility (including skilled nursing facility, long-term care, or rehabilitation facility) or Hospice care.
The primary outcome of interest was 30-day all cause re-admission. Secondary outcomes included CHF-specific 30-day re-admission, 7-day all cause re-admission, in-hospital mortality, and length of stay. For purposes of the study, the very first hospitalization for CHF within the study period was considered the index admission, and subsequent hospitalizations for the same patient were considered readmissions.
The data were analyzed using Epiinfo. Non-parametric variables were compared using the Wilcoxon rank sum test. Differences between means were compared using the analysis of variance (ANOVA) or student t-test. Differences between proportions were compared using the chi-square test. 95% confidence intervals were computed using exact binomials. A two-tailed p-value of <0.05 was considered statistically significant.
Results
A total of 712 patients, with mean age of 75.4 + 14.3, were included in the study. The baseline characteristics of the patients are shown in Table 1 . About 78.9% were aged 65 years or older, 51% were women and the majority (70.7%) was white. Significant co-morbid conditions included hypertension (80.4%), chronic kidney disease stage 3 or worse (52.9%), atrial fibrillation (43.1%) and diabetes mellitus (45.3%).
The median length of stay was 5 days and the overall in-hospital mortality rate was 2.7%. Among the patients discharged from the hospital, the 30-day all cause re-admission rate was 17.7% (95% CI: 14.9% -20.8%). The major reasons for re-admission were CHF exacerbations (43.4%), other cardiac conditions (11.5%), infections Table 2 .
From the univariate analyses, re-admitted patients were more likely to have pre-existing CHF at the time of their initial hospitalization, had prolonged initial hospital stay of at least 7 days, were Black or were discharged to an ECF as shown in Table 3 .
Based on the multivariate logistic regression analyses, the major independent predictors of 30-day re-admission were discharge to an ECF (adjusted Odds ratio [OR] of 2.4, 95% CI 1.54 -3.73; p < 0.001), being Black (adjusted OR 2.4, 95% CI 1.48 -3.83; p = 0.001) and having prior CHF at the time of initial admission (adjusted OR 1.7, 95% CI 1.50 -2.58; p = 0.017) as shown in Table 4 .
Discussion
Readmission from heart failure has emerged as an important, potentially preventable, contributory cause of high hospital expenditure. Multiple factors, including female gender, low income status, single marital status, advanced age, co-morbid conditions (such as depression, coronary artery disease diabetes mellitus, atrial fibrillation, anemia, chronic kidney disease), worsening renal function, elevated cardiac troponin and increased length of initial hospitalization have been identified as potential predictors from previous studies [8] [13] [16] - [20] .
In this retrospective cohort study, based on hospitalized patients in an inner city community-based teaching hospital, many of the prior identified predictors had no significant association with early heart failure re-admission rates. Three factors-prior heart failure diagnosis, discharge to extended care facility, and being of black race, emerged as the most important independent predictors for readmission in our population. The overall 30-day re-admission rate of 17.5% in our institution was lower than the national average and most (56.6%) were for reasons other than worsening heart failure, similar to the findings of Muzzarelli et al. [16] .
The association of black race and increased risk of re-admission in this cohort has been identified in some prior studies [8] [21]- [23] . This excess readmission rate was independent of insurance status or significant co-morbid conditions. It is likely that being black was a surrogate measure of other unmeasured factors such as low income and poor post-discharge follow-up, factors which have been associated with higher re-admission rates in other studies [22] . Prior heart failure found in our study as an independent predictor of early heart failure readmissions has been noted in some other studies [11] [24] . The higher readmission rates for patients discharged to SNF is not new [8] [25] though an earlier study suggested otherwise [21] . Patients discharged to ECF would tend to be older, sicker, less ambulatory, and more Table 2 . In-hospital and readmission outcomes.
Length of stay (IQR) 5 days (3 -7)
In hospital mortality rate 2.7% (95% CI, 1.6% -4.3%) likely to be depressed with their stay at the ECF compared to those discharged home. On one hand, ECF patients are more likely to adhere to their treatment regimens and are also more likely to be readily identified when they begin to decompensate as compared to those discharged home. However, these patients are frailer with multiple comorbidities and poorer performance status. Further studies would be needed to better understand this finding. The study was limited by its retrospective nature, limitation to one institution, lack of exploration of the adequacy of post-discharge follow-up, and the limited information on psycho-social factors. Despite these limitations, the study has identified important predictive factors for 30-day re-admission that might provide initial basis for remedial action. Our study calls for the development of better networks to provide inner city black patients with better follow-up and education, as well as the need for hospitals to partner with ECFs to develop better strategies to manage the complex, elderly HF patient with multiple comorbidities. Once identified with HF, patients need consistent education and follow-up to enhance compliance and ensure they receive appropriate evidence based therapy to improve long term outcomes.
